ADVANCED SALIVARY GLAND CARCINOMA
Clinical trials for ADVANCED SALIVARY GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SALIVARY GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED SALIVARY GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on Hard-to-Treat cancers shows early promise
Disease control OngoingThis early-phase trial tests a combination of two drugs—trastuzumab deruxtecan (a targeted chemotherapy) and ceralasertib (which blocks a DNA repair enzyme)—in people with advanced solid tumors that have a HER2 mutation. The goal is to find the safest dose and see if the combo wo…
Matched conditions: ADVANCED SALIVARY GLAND CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
Personalized treatment shows promise for rare salivary gland cancer
Disease control OngoingThis study tests targeted drugs for advanced salivary gland cancer that has spread or come back. Researchers group patients by genetic markers (like HER-2 or AR) to match them with a specific therapy. The goal is to see if this personalized approach shrinks tumors or slows the di…
Matched conditions: ADVANCED SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC